Contextual factors in value-based decision support to enhance health technologies adoption: the case of biosimilars
IntroductionBiosimilar medicines play a critical role in enhancing global health outcomes by improving access to effective biologic treatments. However, their acceptance and implementation, particularly in emerging markets, depend not only on clinical evidence but also on the integration of societal...
Saved in:
| Main Authors: | Maximilian Otte, Zoltán Kaló, Hussain Abdulrahman Al-Omar, Meindert Boysen, Yingyao Chen, Ana Paula Beck Da Silva Etges, Guvenc Kockaya, Iñaki Gutierrez-Ibarluzea, Ahmed Mohammed Seyam, Deirdre Mullen, Hans-Peter Dauben |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1599013/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Reverberations of the Covid-19-Hit International Diamond Market on Botswana
by: Kalo Makaloba
Published: (2020-06-01) -
Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region
by: Zoltán Kaló, et al.
Published: (2017-01-01) -
Risk management for companies focused on innovation processes
by: Ana Paula Beck da Silva Etges, et al. -
Value-based Reimbursement as a Mechanism to Achieve Social and Financial Impact in the Healthcare System
by: Ana Paula Beck de Silva Etges, et al.
Published: (2023-10-01) -
Editorial: Use of big data and artificial intelligence in multiple sclerosis
by: Liesbet M. Peeters, et al.
Published: (2025-08-01)